Study participants
DISEASE, GROUP B
From October 2021 to April 2022, 30 male patients with mild‐to‐moderate AGA were selected for a randomized double‐blind controlled study. Patients were randomly assigned to two treatment arms: PRP injection combined with topical minoxidil (Group A) and PRP injection combined with topical placebo (Group B). Patients were enrolled with blood routine examinations and filled in questionnaires, including age, duration of disease, previous history, treatment history, family history, etc. Patients were classified according to BASP classification (Basic and specific classification system)Demographic data of subjects at baseline (SD, standard deviation).